why choose us

First received: June 30, 2023

Clinical Trial: A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetic Polyneuropathy

Study Type: INTERVENTIONAL


Official Title: CAT-Trial: CGRP Monoclonal Antibody for Treatment of Painful Diabetic Neuropathy: a Double-blind, Randomized, Placebo-controlled, International Multicenter, Phase II Clinical Trial

Brief Summary: The main purpose of this study is to compare the change in pain intensity during treatment with a CGRP monoclonal antibody (eptinezumab) compared with placebo treatment in patients with painful diabetic polyneuropathy (DPN).

Read more